VitaNova Life Sciences (VNOV) Cash from Discontinued Operations (2017 - 2019)
VitaNova Life Sciences' (VNOV) quarterly Cash from Discontinued Operations came in at 50.0 in Q2 2019, up 99.72% on a QoQ basis from 17649.0 in Q4 2017.
VitaNova Life Sciences (VNOV) Cash from Discontinued Operations (2017 - 2019) Analysis & Trends
VitaNova Life Sciences (VNOV) has 2 years of Cash from Discontinued Operations data on file, last reported at 50.0 in Q2 2019.
- Quarterly Cash from Discontinued Operations changed N/A year-over-year to 50.0 in Q2 2019, while the trailing twelve-month figure through Apr 2020 was 50.0 (changed N/A YoY) and the FY2019 annual result came in at 57054.0, up 840.96% from the prior year.
- Cash from Discontinued Operations climbed to 50.0 in Q2 2019, from 17649.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 50.0 in Q2 2019 to a low of 17649.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | - |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | - |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | - |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | - |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2019 | -50.00 |
| Apr 30, 2019 | -50.00 |
| Oct 31, 2017 | -17,649.00 |
| Oct 31, 2017 | -17,649.00 |